Sara Nik

Stock Analyst at HC Wainwright & Co.

(3.16)

# 1,198

Out of 5,090 analysts

7

Total ratings

66.67%

Success rate

92.49%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CDTX Cidara Therapeutics	Downgrades: Neutral	n/a	$220.36	-	5	Nov 14, 2025
	MBRX Moleculin Biotech	Reiterates: Buy	$100	$7.24	+1,281.22%	2	Sep 10, 2025

Cidara Therapeutics

Nov 14, 2025

Downgrades: Neutral

Price Target: n/a

Current: $220.36

Upside: -

Moleculin Biotech

Sep 10, 2025

Reiterates: Buy

Price Target: $100

Current: $7.24

Upside: +1,281.22%